Niranjan Sardesai

Niranjan Sardesai is Founder & CEO of Geneos Therapeutics, a Phase 2 clinical stage biopharmaceutical company focused on personalized immunotherapies for cancer. His expertise spans broad aspects of biopharmaceutical development as relates to vaccines and cancer immunotherapies. He founded Geneos with the vision of democratizing personalized cancer treatments - a vision the company is realizing with its proprietary DNA based therapeutic platform.